Why the study?
GDMT is underutilized among eligible patients with HFrEF, but whether this reflects medication intolerance, contraindications, or quality of care issues remains unclear.
Population
500 HFrEF patients enrolled in a quality improvement project at a tertiary center
Design
Quality improvement initiative / observational study
Authors
Loading...
Target-dose GDMT under-dosing in HFrEF often lacks documented rationale; hypothesis-generating for quality improvement but should not yet change practice.
Guideline-directed medical therapy for HFrEF is frequently underutilized and under-dosed in clinical practice, often without documented clinical rationale, highlighting a major opportunity for quality improvement.
Smith et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: